Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2012
08/09/2012WO2012105815A2 Biodegradable paox microspheres having cationic properties
08/09/2012WO2012105708A1 Novel crystal of tetrahydronaphthalene compound
08/09/2012WO2012105635A1 2-oxy-substituted 8-oxodihydropurine derivative
08/09/2012WO2012105477A1 Analgesic
08/09/2012WO2012105467A1 Oligonucleic acid composition and antiallergic agent
08/09/2012WO2012105312A1 Arthritis prevention/amelioration substance
08/09/2012WO2012104706A1 New combination for the treatment of pain
08/09/2012WO2012103637A1 Functional foods and beverages with synergistic properties to promote homeostasis
08/09/2012WO2012103583A1 Positive allosteric modulators of the alpha 7 nicotinic acetylcholine receptor and uses thereof.
08/09/2012WO2012103570A1 Composition comprising b group vitamins or feverfew and treatment of headaches with such compositions
08/09/2012WO2012027652A3 Methods and compositions for treating inflammation
08/09/2012WO2011156451A3 Compositions and methods for modulating toll-like receptor 2 activation
08/09/2012WO2011133790A3 Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain
08/09/2012US20120204276 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis
08/09/2012US20120202892 Cannabinoid-Containing Compositions and Methods for Their Use
08/09/2012US20120202882 Permeation enhancers for topical formulations
08/09/2012US20120202875 Method Of Treatment
08/09/2012US20120202874 Antisense oligonucleotide modulation of stat3 expression
08/09/2012US20120202870 Treatment of inflammatory diseases using mir-124
08/09/2012US20120202869 Antidepressant Oral Pharmaceutical Compositions
08/09/2012US20120202862 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
08/09/2012US20120202861 Novel estrogen receptor ligands
08/09/2012US20120202848 Therapy of autoimmune colitis using a tip60 inhibitor
08/09/2012US20120202841 Topical Compositions Comprising Ascomycins
08/09/2012US20120202818 Ureidophenyl substituted triazine derivatives and their therapeutical applications
08/09/2012US20120202817 Compounds having 4-pyridylalkylthio group as a substituent
08/09/2012US20120202812 Heteroaryls and uses thereof
08/09/2012US20120202809 Novel n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as pkc kinase inhibitors
08/09/2012US20120202807 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
08/09/2012US20120202805 PI3K (delta) SELECTIVE INHIBITORS
08/09/2012US20120202802 Spirocyclic compounds as modulators of chemokine receptor activity
08/09/2012US20120202799 Condensed Azepine Derivatives As Bromodomain Inhibitors
08/09/2012US20120202798 COMPOSITIONS CONTROLLING pH RANGE OF RELEASE AND/OR RELEASE RATE
08/09/2012US20120202788 Azabenzothiazole compounds, compositions and methods of use
08/09/2012US20120202785 Heterocyclic compounds and methods of use
08/09/2012US20120202782 Compounds and compositions as itpkb inhibitors
08/09/2012US20120202780 Carrier composition
08/09/2012US20120202774 Acyloxy- and phosphoryloxy-butadiene-fe(co)3 complexes as enzyme-triggered co-releasing molecules
08/09/2012US20120202763 Methods for treating cancer and non-neoplastic conditions
08/09/2012US20120202758 Core 2glcnac-t inhibitors
08/09/2012US20120202753 Inhibiting inflammation with milk oligosaccharides
08/09/2012US20120202744 Dual antagonism of endothelin type a and bradykinin b1 receptors for treating pain and preventing cartilage degradation
08/09/2012US20120202735 Antimicrobial cationic peptides and formulations thereof
08/09/2012US20120202733 Inhibition of trem receptor signaling with peptide variants
08/09/2012US20120202695 Core stabilized microcapsules, method of their preparation and uses thereof
08/09/2012US20120201914 Method and Composition for Improving Animal Oral Health
08/09/2012US20120201903 Cytoprotective or therapeutic plant composition
08/09/2012US20120201889 Modified and immediate release formulations of memantine
08/09/2012US20120201888 Pharmaceutical Compositions
08/09/2012US20120201884 Extracts, fractions and compositions comprising acetogenins and their applications
08/09/2012US20120201876 Method of managing hypercortisolemia, headache disorders, neuropathic pain and related disorders
08/09/2012US20120201872 Liposomes comprising a calcium phosphate-containing precipitate
08/09/2012US20120201871 Permeation enhancers with liposomes for topical formulations
08/09/2012US20120201859 Drug Delivery Systems and Use Thereof
08/09/2012US20120201858 Multiple-arm peptide compounds, methods of manufacture and use in therapy
08/09/2012US20120201856 Use of Mycobacterium Bovis BCG killed by Extended Freeze Drying (EFD) For Preventing or Treating Atherosclerosis
08/09/2012US20120201836 Methods and compositions for modulating t cell and/or b cell activation
08/09/2012US20120201831 Human antibodies that bind human il-12 and methods for producing
08/09/2012US20120201830 Compositions and methods for treating macular edema
08/09/2012US20120201827 Anti-cd38 antibodies
08/09/2012US20120201826 Anti-RANTES Antibodies and Methods of Use Thereof
08/09/2012US20120201821 Treatment of Gastrointestinal Inflammation and Psoriasis and Asthma
08/09/2012US20120201819 Treatment of drug-related side effect and tissue damage by targeting the cd-24-hmgb1-siglec10 axis
08/09/2012US20120201818 Treatment of multiple sclerosis
08/09/2012US20120201814 Compositions monovalent for cd28 binding and methods of use
08/09/2012US20120201799 Devices, systems and methods for cell modification
08/09/2012US20120201791 Methods of treating diseases or conditions using mesenchymal stem cells
08/09/2012US20120201785 Use of bifidobacterium longum for the prevention and treatment of inflammation
08/09/2012US20120201769 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
08/09/2012US20120201756 Plasma kallikrein binding proteins
08/09/2012US20120201753 Methods and compositions related to targeting wounds, regenerating tissue, and tumors
08/09/2012US20120201748 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof
08/09/2012CA2837751A1 Functional foods and beverages with synergistic properties to promote homeostasis
08/09/2012CA2826662A1 Treatment of bacterial infections
08/09/2012CA2826356A1 Substance for preventing and improving arthritis
08/09/2012CA2826262A1 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
08/09/2012CA2826114A1 Cardiotrophin related molecules for enhanced therapeutics
08/09/2012CA2824750A1 Analgesic
08/09/2012CA2817841A1 1,4 oxazines as bace1 and/or bace2 inhibitors
08/08/2012EP2484664A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
08/08/2012EP2484661A1 2,3-dihydro-1h-indene-2-ylurea derivative and pharmaceutical application of same
08/08/2012EP2484381A1 Composition for a treatment of demyelinating diseases and paralysis by administration of remyelinating agents
08/08/2012EP2484363A1 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-5-methylthiophene-2-carboxamide
08/08/2012EP2484361A1 Agent for reducing visceral fat weight
08/08/2012EP2484353A1 Oral composition for alleviation of ultraviolet radiation-induced damage
08/08/2012EP2483280A1 New aminoacid derivatives, their process of preparation and their therapeutical uses as inhibitors of oncogenic signals by the met family
08/08/2012EP2483268A1 Pyridinyl-imidazolone derivatives for inhibiting pi3 kinases
08/08/2012EP2483246A1 Process for preparing biphenyl imidazole compounds
08/08/2012EP2483244A1 2-pyridone compounds used as inhibitors of neutrophil elastase
08/08/2012EP2482854A2 Agents, uses and methods
08/08/2012EP2482850A2 Topical formulations
08/08/2012EP2482830A1 Extracts of phyllanthus niruri
08/08/2012EP2482827A1 Antioxidants for use in therapy
08/08/2012EP2482815A1 Anti inflammatory 2-oxothiazoles and 2 -oxooxazoles
08/08/2012EP2482661A1 Reversed biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
08/08/2012EP2268632B1 Tertiary amine derivatives as phosphodiesterase-4 inhibitors
08/08/2012EP2152753B1 Antibodies against ramp3
08/08/2012EP2152369B1 Use of fluoride-containing compounds for diagnostic purposes with the help of imaging processes
08/08/2012EP2121693B1 8-oxoadenine derivatives as immuno-modulators
08/08/2012EP1933861B1 Method for treating or preventing multi-organ failure
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 1272